Mariner
TARA icon

Mariner’s Protara Therapeutics TARA Stock Holding History

Mariner’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Buy
+11,899
New +$56.6K ﹤0.01% 3420
2019
Q2 		– Sell
-250
Closed -$5K – 1148
2019
Q1 		$5K Hold
250
– – ﹤0.01% 1028
2018
Q4 		$23K Hold
250
– – ﹤0.01% 828
2018
Q3 		$20K Hold
250
– – ﹤0.01% 804
2018
Q2 		$25K Hold
250
– – ﹤0.01% 782
2018
Q1 		$25K Hold
250
– – ﹤0.01% 633
2017
Q4 		$19K Hold
250
– – ﹤0.01% 575
2017
Q3 		$20K Hold
250
– – ﹤0.01% 502
2017
Q2 		$15K Sell
250
-28
-10% -$1.57K ﹤0.01% 498
2017
Q1 		$19K Hold
278
– – ﹤0.01% 585
2016
Q4 		$21K Buy
+278
New +$87.9K ﹤0.01% 557

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Mariner's TARA Position: Q2 2026 in Review

Mariner opened a new position in Protara Therapeutics (TARA) in Q2 2026: 11,899 shares worth $45.4K. The stake represents ﹤0.01% of the portfolio and ranks #3420 among its holdings. This is a return to the name: Mariner previously reported a position in TARA as recently as Q1 2019.

Mariner first reported a position in TARA in Q4 2016 and has held it in 11 quarters since. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Mariner held 11,899 shares of Protara Therapeutics worth $45.4K as of Q2 2026.
  • Protara Therapeutics was a new Mariner position in Q2 2026.
  • Protara Therapeutics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3420 holding.
  • Mariner first reported a position in Protara Therapeutics in Q4 2016 and has held it in 11 quarters since.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.